Citius Pharmaceuticals, Inc. - stock earnings
CTXR Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.2 million USD | ? USD |
| 2023Q3 | -9.9 million USD | ? USD |
| 2023Q2 | -8.5 million USD | ? USD |
| 2023Q1 | -10.5 million USD | ? USD |
| 2022Q4 | -3.6 million USD | ? USD |
| 2022Q3 | -8.0 million USD | ? USD |
| 2022Q2 | -8.8 million USD | ? USD |
| 2022Q1 | -7.5 million USD | ? USD |
| 2021Q4 | -9.2 million USD | ? USD |
| 2021Q3 | -5.0 million USD | ? USD |
| 2021Q2 | -5.8 million USD | ? USD |
| 2021Q1 | -4.1 million USD | ? USD |
| 2020Q4 | -8.1 million USD | ? USD |
| 2020Q3 | -4.1 million USD | ? USD |
| 2020Q2 | -4.7 million USD | ? USD |
| 2020Q1 | -4.4 million USD | ? USD |
| 2019Q4 | -4.3 million USD | ? USD |
| 2019Q3 | -3.6 million USD | ? USD |
| 2019Q2 | -4.4 million USD | ? USD |
| 2019Q1 | -3.6 million USD | ? USD |
| 2018Q4 | -3.9 million USD | ? USD |
| 2018Q3 | -2.8 million USD | ? USD |
| 2018Q2 | -2.0 million USD | ? USD |
| 2018Q1 | -4.4 million USD | ? USD |
| 2017Q4 | -3.2 million USD | ? USD |
| 2017Q3 | -3.0 million USD | ? USD |
| 2017Q2 | -2.4 million USD | ? USD |
| 2017Q1 | -2.7 million USD | ? USD |
| 2016Q4 | -2.2 million USD | ? USD |
| 2016Q3 | -2.6 million USD | ? USD |
| 2016Q2 | -3.6 million USD | ? USD |
| 2016Q1 | -869454 USD | ? USD |
| 2015Q4 | -1.2 million USD | ? USD |
| 2015Q3 | -908320 USD | ? USD |
| 2015Q2 | -824972 USD | ? USD |
| 2015Q1 | -345268 USD | ? USD |
| 2014Q4 | -823708 USD | ? USD |
| 2014Q3 | -610000 USD | ? USD |
| 2014Q2 | -6297 USD | ? USD |
| 2014Q1 | -10005 USD | ? USD |
| 2013Q4 | -15288 USD | ? USD |
| 2013Q3 | -15288 USD | ? USD |
| 2013Q2 | -4432 USD | ? USD |
| 2013Q1 | -10229 USD | ? USD |
| 2012Q4 | -5392 USD | ? USD |
| 2012Q3 | -5392 USD | ? USD |
| 2012Q2 | -6836 USD | ? USD |
| 2012Q1 | -7210 USD | ? USD |
| 2011Q4 | -2758 USD | ? USD |
| 2011Q3 | -2758 USD | ? USD |
| 2011Q2 | -7315 USD | ? USD |
| 2011Q1 | -7260 USD | ? USD |
| 2010Q4 | -9008 USD | ? USD |
CTXR Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -32.5 million USD | ? USD |
| 2022 | -33.6 million USD | ? USD |
| 2021 | -23.1 million USD | ? USD |
| 2020 | -17.7 million USD | ? USD |
| 2019 | -15.6 million USD | ? USD |
| 2018 | -12.5 million USD | ? USD |
| 2017 | -10.4 million USD | ? USD |
| 2016 | -8.3 million USD | ? USD |
| 2015 | -2.9 million USD | ? USD |
| 2014 | -1.3 million USD | ? USD |
| 2013 | -31369 USD | ? USD |
| 2012 | -22006 USD | ? USD |
| 2011 | -26341 USD | ? USD |
CTXR
Price: $0.70
52 week price:
Earnings Per Share: -0.26 USD
P/E Ratio: -3.83
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 674400
Ebitda: -9.5 millionMarket Capitalization: 121.9 million